Purdue Univeristy
West Lafayette, Indiana, 47907, United States
NCT Number: NCT02999321
Assess the impact of chronic use of aspartame on glycemia, appetite and body composition.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
West Lafayette, Indiana, 47907, United States
Participants will be randomly assigned to one of three parallel arms: 0% (water), 5 mg, 15mg aspartame. Participants will have an oral glucose tolerance test at the beginning and end of a 12 week intervention. . Participants will report to the lab weekly for 12 weeks to pick up their next week's intervention products and measurements for body weight, waist circumference, blood pressure and heart rate. They will consume their intervention products daily for 12 weeks. They will record appetite sensations and collect a 24 hour urine sample at weeks 0, 4, 8, and 12.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
will be given 5mg aspartame or 15 mg aspartame
control group
Time frame: week 0 4 hours
sample taken at time point 0
Time frame: week 0 4 hours
sample taken at time point 15 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 30 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 60 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 90 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 120 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 180 minutes post glucola
Time frame: week 0 4 hours
sample taken at time point 240 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 0
Time frame: week 12 4 hours
sample taken at time point 15 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 30 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 60 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 90 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 120 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 180 minutes post glucola
Time frame: week 12 4 hours
sample taken at time point 240 minutes post glucola
Time frame: every hour for 1 day at week 0
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day.
Time frame: every hour for 1 day at week 4
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
Time frame: every hour for 1 day at week 8
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
Time frame: every hour for 1 day at week 12
questionnaire on hunger, fullness, desire to eat, prospective consumption, thirst taken hourly for one day
Time frame: week 0
body composition measurement Plysmography (BOD POD)
Time frame: week 12
body composition measurement Plysmography (BOD POD)
Purdue University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02417519
Glucose Metabolism Disorders, Hyperinsulinism
Frederiksberg, Denmark
View Trial DetailsNCT05441982
Continuous Glucose Monitoring, Glucose Metabolism Disorders
Blacksburg, Virginia, United States
View Trial DetailsNCT05337098
Continuous Glucose Monitoring, Glucose Metabolism Disorders
Blacksburg, Virginia, United States
View Trial Details